NextCure, Inc. (NXTC): Capital Expenditures
$474.0K
Year ended 2024-12-31
-41.4%
3-year compound annual growth
-32.5%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $474.0K | -42.2% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $820.0K | -61.2% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $2.12M | -10.3% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $2.36M | -66.9% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | $7.13M | +111.6% | 2022-03-03, From 2020-01-01 |
| 2019-12-31 | $3.37M | +10.1% | 2021-03-04, From 2019-01-01 |
| 2018-12-31 | $3.06M | n/a | 2020-03-12, From 2018-01-01 |